Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.
Clinical trial NCT07717450 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07717450
- Sponsor
- UNICANCER
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-25
- Primary completion
- 2032-06-25
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.